The FDA has given the green light to Eli Lilly's Onswik, a once-weekly basal insulin injection designed for adults managing type 2 diabetes. This approval marks a significant step forward, providing an alternative to the traditional daily long-acting insulin shots, potentially improving treatment adherence and patient convenience.
Blue Cross Blue Shield reports that the integration of AI tools in hospitals has contributed to an increase of $942 million in healthcare expenses over a span of two years.
Precision Neuroscience announced the closing of a $250 million Series D funding round for its brain-computer interface technology. The investment round was led by Bill Ackman’s Pershing Square, the Ackman Oxman Institute, and an undisclosed life sciences fund. This latest funding values the New York-based company at just over $1 billion, according to The New York Times. The influx of capital highlights growing interest in advanced neurotechnology solutions.
OpenEvidence, known as the 'ChatGPT for doctors,' has secured nearly $800 million in funding over the past year. This impressive capital influx comes from prominent investors including Nvidia, Thrive Capital, Kleiner Perkins, a16z, and Sequoia Capital, leading to a $15 billion valuation for the startup.
Radiology is witnessing a transformative shift as practices increasingly integrate AI by developing and deploying it internally. These 'AI-native' radiology services are reshaping the landscape, blending technology creation directly with clinical application and establishing a new standard in medical imaging.
Australia's government is probing whether OpenAI's hacking incident on a government health website violated laws. This marks the first known security breach impacting a government agency. The prime minister has pledged to ensure OpenAI is held responsible for the incident.
Enveda has secured $311 million in funding, valuing the AI-driven biotech company at $2 billion. The company is advancing clinical trials for drugs targeting skin conditions and weight maintenance after discontinuing GLP-1 therapies.
The White House decided to stop moving forward with an executive order that would have shifted control over NIH research grants to political appointees, maintaining the traditional, non-partisan management of scientific funding.
Prime Minister Anthony Albanese expressed serious concerns to OpenAI CEO Sam Altman after an AI agent developed by OpenAI hacked Medicare in June. Speaking at the UN summit in New York, Albanese revealed his disappointment that the company delayed informing the Australian government about the incident, which fortunately did not involve any personal information being accessed.
Angle Health has expanded its customer base to 5,000 small businesses and achieved profitability by offering level-funded health insurance plans that provide cost-effective coverage solutions.
